Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-01
1995-10-24
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514342, 514365, 514369, 514370, 514372, 514374, 514376, 514377, 514378, 514380, 546256, 546275, 546280, 548182, 548183, 548184, 548186, 548187, 548189, 548190, 548191, 548194, 548213, 548214, 548204, 548225, 548226, 548227, 548228, 548229, 548233, 548234, 548235, 548236, 548243, 548244, 548245, 548246, 548247, 548248, A61K 3144, A61K 31425, A61K 3142, C07D41314, C07D41714, C07D26330, C07D27720
Patent
active
054610672
ABSTRACT:
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed wherein R.sub.1, R.sub.2, R.sub.5, R.sub.6, Y.sub.m and Y'.sub.n are herein defined.
Kempf Dale J.
Norbeck Daniel W.
Sham Hing L.
Zhao Chen
Abbott Laboratories
Crowley Steven R.
Henley III Raymond
Spivack Phyllis G.
LandOfFree
Retroviral protease inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibiting compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1886928